Embecta Corp (EMBC): Kapitalisasi marang pendapatan
Embecta Corp. maintains a dominant position in the insulin syringe segment, generating a steady profit stream through automation. The rising number of diabetics and the launch of patch pumps drive growth, while flawless patient trust ensures stability. The price-to-sales ratio visualizes market expectations, with the current mark equal to 0.40, allowing for an assessment of the fairness of the current capitalization.
Rincian analitis perusahaan Embecta Inc. (EMBC)
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- indikator nilai buku ekuitas:
- statistik kawajiban utang lan likuiditas:
Koefisien Total Utang marang Modal Embecta Corp.|EMBC - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Embecta Health|EMBC - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Embecta Inc.|EMBC - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Embecta|Rasio jangkoan perantara embecta.com
- data bathi lan kelipatan valuasi:
EMBC - Bathi resik|Bathi resik sing dikarepake Embecta Corp.|EMBC - Rasio rega marang bathi|Pangali forward rega marang bathi Embecta Corp|EMBC - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Embecta Inc.|EMBC - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Embecta|EMBC - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan embecta.com|EMBC - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Embecta Corp.
- rincian pendapatan lan dodolan emiten:
Analisis umum perusahaan:EMBC embecta.com
Stable demand for Embecta Corp. (EMBC) medical devices makes the price-to-sales ratio a reliable tool for valuing a business shielded from macroeconomic volatility. This metric is calculated as the ratio of market capitalization to annual sales volume, allowing investors to determine whether an asset is overvalued or to identify a discounted entry point while product sales maintain steady growth rates.
Pesaing Embecta Corp.
BSX (bostonscientific.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Edwards Lifesciences Corporation EW|RMD - Kapitalisasi marang pendapatan|OmniPod - Multiplikator P/S|Rega marang dodolan Zimmer Biomet Holdings|COO: Multiplikator P/S|Rasio kapitalisasi marang pendapatan ALGN|GMED (Globus Medical) - Multiplikator P/S|TransMedics Group Inc (TMDX) - Koefisien rega marang pendapatan|Multiplikator P/S ATEC|Kapitalisasi marang pendapatan Artivion Corp AORT|Multiplikator P/S ENOV (Enovis Corporation)|Multiplikator P/S integralife.com IART|ESTA - Rasio rega marang pendapatan|BBNX: Rasio rega marang pendapatan|IRMD (Iradimed) - Kapitalisasi marang pendapatan|Tandem Corp - Rasio kapitalisasi pasar marang pendapatan|AXGN (AxoGen, Inc.) - Multiplikator P/S|Rega marang dodolan si-bone.com SIBN|Rasio rega marang pendapatan Orthofix (OFIX)|Bioventus Inc (BVS) - Multiplikator rega marang pendapatan|OrthoPediatrics - Kapitalisasi marang pendapatan|Multiplikator P/S Treace Corp TMCI|Strata Critical Medical Inc - Multiplikator P/S|Koefisien rega marang pendapatan carlsmed.com CARL|RxSight (RXST) - Rasio rega marang pendapatan|Rasio rega marang dodolan CLPT (ClearPoint Neuro)|Rasio rega marang pendapatan Stereotaxis Corp|Kapitalisasi marang pendapatan Neuronetics, Inc (STIM)|Multiplikator P/S SGHT|OBIO - Rega marang dodolan|Rasio rega marang pendapatan Anika Therapeutics, Inc. ANIK|NSPR: Rasio kapitalisasi marang pendapatan|ZJYL: Kapitalisasi marang pendapatan|Vivani Medical, Inc. - Kapitalisasi marang volume dodolan|XTNT: Multiplikator P/S|Rega marang dodolan n1mtc.com (NMTC)|Rasio rega marang pendapatan Modular Medical Inc|Kapitalisasi marang pendapatan Myomo Inc. (MYO)|Multiplikator P/S COCH|Rasio rega marang pendapatan VVOS (Vivos Therapeutics Inc)|Multiplikator P/S NVNO (enVVeno Medical)|Sintx Technologies Inc (SINT) - Rega marang dodolan|Tenon Medical - Multiplikator P/S|ReWalk Robotics (LFWD) - Kapitalisasi marang pendapatan|AMIX (autonomix.com) - Kapitalisasi marang pendapatan|IVF: Kapitalisasi marang volume dodolan|BBLG (Bone Biologics) - Multiplikator P/S|Multiplikator P/S axonics.com|Kapitalisasi marang pendapatan BIOL (BIOLASE)|DYNT (dynatronics.com) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S FNA (Paragon 28)|INVO - Kapitalisasi marang pendapatan
